Journal articleAm J Clin Oncol2021
Pancreatic Cancer Clinical Treatment Trials Accrual: A Closer Look at Participation Rates.
- Journal
- Am J Clin Oncol
- Published
- 1 June 2021
- Citations
- 3
- Type
- Article
These are the paper’s bibliographic details. A summary of its population, design, endpoints and findings, each tied to a quote, has not been written for this paper yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.
Try
Source text
abstract license unknown
Objectives Low rates of participation in cancer clinical trials are commonly reported, raising concerns about missed opportunities to engage patients in treatment trials. We reviewed eligibility for and enrollment in pancreatic cancer clinical trials for patients seen at a National Cancer Institute (NCI)-designated cancer center during 1 year, to calculate participation rates with detailed information to determine the best-case participation rate. … Excerpt only: this text is the publisher’s. Read it in full at the source.